Vanda Pharmaceuticals Announces Presentations at DDW 2022

WASHINGTON, May 19, 2022 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at Digestive Disease Week (DDW) 2022, to be held in San Diego, CA and online from May 21-24, 2022. The following will be presented: May 21, 2022 Presentation Title:…

Click here to view original post